CONCERT PHARMACEUTICALS INC's ticker is CNCE and the CUSIP is 206022105. A total of 67 filers reported holding CONCERT PHARMACEUTICALS INC in Q2 2015. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $736,000 | +1.8% | 71,478 | 0.0% | 0.00% | 0.0% |
| Q3 2016 | $723,000 | -0.3% | 71,478 | +10.8% | 0.00% | 0.0% |
| Q2 2016 | $725,000 | -5.1% | 64,532 | +15.4% | 0.00% | 0.0% |
| Q1 2016 | $764,000 | -26.5% | 55,931 | +2.0% | 0.00% | 0.0% |
| Q4 2015 | $1,040,000 | +1.9% | 54,822 | +0.8% | 0.00% | 0.0% |
| Q3 2015 | $1,021,000 | +26.2% | 54,379 | +0.1% | 0.00% | 0.0% |
| Q2 2015 | $809,000 | +3945.0% | 54,338 | +3949.0% | 0.00% | – |
| Q1 2015 | $20,000 | +33.3% | 1,342 | +21.3% | 0.00% | – |
| Q4 2014 | $15,000 | +7.1% | 1,106 | 0.0% | 0.00% | – |
| Q3 2014 | $14,000 | +27.3% | 1,106 | +3.8% | 0.00% | – |
| Q2 2014 | $11,000 | -95.2% | 1,066 | -93.7% | 0.00% | – |
| Q1 2014 | $229,000 | – | 17,052 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 3,135,289 | $46,246,000 | 5.88% |
| GREAT POINT PARTNERS LLC | 2,006,211 | $29,592,000 | 5.76% |
| Lyon Street Capital, LLC | 463,064 | $6,830,000 | 2.63% |
| SENZAR ASSET MANAGEMENT, LLC | 335,445 | $4,948,000 | 1.21% |
| INGALLS & SNYDER LLC | 1,209,062 | $17,834,000 | 0.93% |
| Senvest Management, LLC | 314,629 | $4,641,000 | 0.31% |
| KNOTT DAVID M | 45,000 | $664,000 | 0.28% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 262,569 | $3,873,000 | 0.15% |
| PRINCETON CAPITAL MANAGEMENT INC | 14,607 | $215,000 | 0.11% |
| Manchester Capital Management LLC | 19,984 | $295,000 | 0.05% |